XBI icon

SPDR S&P Biotech ETF

227 hedge funds and large institutions have $3.11B invested in SPDR S&P Biotech ETF in 2016 Q3 according to their latest regulatory filings, with 49 funds opening new positions, 70 increasing their positions, 60 reducing their positions, and 20 closing their positions.

Holders
227
Holders Change
+26
Holders Change %
+12.94%
% of All Funds
6.07%
Holding in Top 10
6
Holding in Top 10 Change
+4
Holding in Top 10 Change %
+200%
% of All Funds
0.16%
New
49
Increased
70
Reduced
60
Closed
20
Calls
$724M
Puts
$1.04B
Net Calls
-$319M
Net Calls Change
+$22.3M
Name Market Value Shares Shares
Change
Shares
Change %
SGH
251
Sivik Global Healthcare
Connecticut
TI
252
Telemetry Investments
New York
AWM
253
Avior Wealth Management
Nebraska
EAM
254
EverPoint Asset Management
Connecticut
FO
255
FT Options
Illinois
BC
256
Broadfin Capital
New York
CF
257
CenterStar Fund
Illinois
CI
258
Cowen Inc
New York
ACPU
259
Arrowgrass Capital Partners (US)
Delaware
HT
260
HAP Trading
New York
UOC
261
UBS O'Connor
Illinois
JGC
262
J. Goldman & Co
New York
Balyasny Asset Management
263
Balyasny Asset Management
Illinois
ICM
264
Ionic Capital Management
New York
Millennium Management
265
Millennium Management
New York
KCM
266
Kingdon Capital Management
New York
QF
267
QVT Financial
New York
ACP
268
Acuta Capital Partners
California
MIG
269
Mariner Investment Group
New York
CC
270
Casdin Capital
New York
Jennison Associates
271
Jennison Associates
New York
JT
272
Jump Trading
Illinois
HCMT
273
Highland Capital Management (Texas)
Texas
ACM
274
Atika Capital Management
New York
JFGIW
275
Johnson Financial Group Inc (Wisconsin)
Wisconsin